Caseware UK (AP4) 2024.0.164 2024.0.164 2025-03-302025-03-30No description of principal activitytrue2024-03-31false11falseThe members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.false 09276590 2024-03-31 2025-03-30 09276590 2023-03-31 2024-03-30 09276590 2025-03-30 09276590 2024-03-30 09276590 c:Director1 2024-03-31 2025-03-30 09276590 d:OfficeEquipment 2024-03-31 2025-03-30 09276590 d:OfficeEquipment 2025-03-30 09276590 d:OfficeEquipment 2024-03-30 09276590 d:OfficeEquipment d:OwnedOrFreeholdAssets 2024-03-31 2025-03-30 09276590 d:ComputerEquipment 2024-03-31 2025-03-30 09276590 d:ComputerEquipment 2025-03-30 09276590 d:ComputerEquipment 2024-03-30 09276590 d:ComputerEquipment d:OwnedOrFreeholdAssets 2024-03-31 2025-03-30 09276590 d:OwnedOrFreeholdAssets 2024-03-31 2025-03-30 09276590 d:CurrentFinancialInstruments 2025-03-30 09276590 d:CurrentFinancialInstruments 2024-03-30 09276590 d:CurrentFinancialInstruments d:WithinOneYear 2025-03-30 09276590 d:CurrentFinancialInstruments d:WithinOneYear 2024-03-30 09276590 d:ShareCapital 2025-03-30 09276590 d:ShareCapital 2024-03-30 09276590 d:RetainedEarningsAccumulatedLosses 2025-03-30 09276590 d:RetainedEarningsAccumulatedLosses 2024-03-30 09276590 c:OrdinaryShareClass1 2024-03-31 2025-03-30 09276590 c:OrdinaryShareClass1 2025-03-30 09276590 c:OrdinaryShareClass1 2024-03-30 09276590 c:OrdinaryShareClass2 2024-03-31 2025-03-30 09276590 c:OrdinaryShareClass2 2025-03-30 09276590 c:OrdinaryShareClass2 2024-03-30 09276590 c:OrdinaryShareClass3 2024-03-31 2025-03-30 09276590 c:OrdinaryShareClass3 2025-03-30 09276590 c:OrdinaryShareClass3 2024-03-30 09276590 c:FRS102 2024-03-31 2025-03-30 09276590 c:AuditExempt-NoAccountantsReport 2024-03-31 2025-03-30 09276590 c:FullAccounts 2024-03-31 2025-03-30 09276590 c:PrivateLimitedCompanyLtd 2024-03-31 2025-03-30 09276590 2 2024-03-31 2025-03-30 09276590 e:PoundSterling 2024-03-31 2025-03-30 xbrli:shares iso4217:GBP xbrli:pure
Registered number: 09276590














HEALTHCARE INVOICE FINANCE LIMITED
UNAUDITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED  30 MARCH 2025

 
HEALTHCARE INVOICE FINANCE LIMITED
 

CONTENTS



Page
Statement of Financial Position
 
1
Notes to the Financial Statements
 
2 - 5


 
HEALTHCARE INVOICE FINANCE LIMITED
REGISTERED NUMBER:09276590

STATEMENT OF FINANCIAL POSITION
AS AT 30 MARCH 2025

2025
2024
Note
£
£

Fixed assets
  

Tangible assets
 4 
6,975
5,154

Current assets
  

Debtors: amounts falling due within one year
 5 
115,120
25,491

Cash at bank and in hand
  
272,225
195,480

  
387,345
220,971

Current liabilities
  

Creditors: amounts falling due within one year
 6 
(253,492)
(119,511)

Net current assets
  
 
 
133,853
 
 
101,460

  

Net assets
  
140,828
106,614


Capital and reserves
  

Called up share capital 
 7 
9
9

Profit and loss account
  
140,819
106,605

  
140,828
106,614


The Director considers that the Company is entitled to exemption from audit under section 477 of the Companies Act 2006 and members have not required the Company to obtain an audit for the year in question in accordance with section 476 of the Companies Act 2006.

The Director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The financial statements have been prepared in accordance with the provisions applicable to companies subject to the small companies regime and in accordance with the provisions of FRS 102 Section 1A - small entities.

The financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The Company has opted not to file the statement of comprehensive income in accordance with provisions applicable to companies subject to the small companies' regime.

The financial statements were approved and authorised for issue by the board and were signed on its behalf on 2 December 2025.




P J Sherrington
Director

The notes on pages 2 to 5 form part of these financial statements.

Page 1

 
HEALTHCARE INVOICE FINANCE LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 MARCH 2025

1.


General information

Healthcare Invoice Finance Limited is a limited liability company registered in England and Wales. Its registered office address is at 20-22 Wenlock Road London, N1 7GU.
The principal activity of the Company during the year was that of providing invoice factoring services.
The financial statements are presented in £ sterling, which is the functional currency of the Company.

2.Accounting policies

 
2.1

Basis of preparation of financial statements

The financial statements have been prepared under the historical cost convention unless otherwise specified within these accounting policies and in accordance with FRS 102 'The Financial Reporting Standard applicable in the UK and the Republic of Ireland' and the requirements of the Companies Act 2006. The disclosure requirements of Section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The following principal accounting policies have been applied:

 
2.2

Turnover

Turnover is measured at the fair value of amounts receivable in respect of services provided in the year, net of trade discounts and excluding value added tax. Revenue from services is recognised when all contractual obligations have been met.

 
2.3

Tangible fixed assets

Tangible fixed assets under the cost model are stated at historical cost less accumulated depreciation and any accumulated impairment losses. Historical cost includes expenditure that is directly attributable to bringing the asset to the location and condition necessary for it to be capable of operating in the manner intended by management.

At each reporting date the Company assesses whether there is any indication of impairment. If such indication exists, the recoverable amount of the asset is determined which is the higher of its fair value less costs to sell and its value in use. An impairment loss is recognised where the carrying amount exceeds the recoverable amount.

Depreciation is charged so as to allocate the cost of assets less their residual value over their estimated useful lives, using the straight-line method.

Depreciation is provided on the following basis:

Office equipment
-
25%
straight line
Computer equipment
-
25%
straight line

The assets' residual values, useful lives and depreciation methods are reviewed, and adjusted prospectively if appropriate, or if there is an indication of a significant change since the last reporting date.

Gains and losses on disposals are determined by comparing the proceeds with the carrying amount and are recognised in profit or loss.

Page 2

 
HEALTHCARE INVOICE FINANCE LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 MARCH 2025

2.Accounting policies (continued)

 
2.4

Basic financial instruments

The Company only enters into transactions that result in basic financial instruments such as trade and other debtors, trade and other creditors, cash at bank and in hard, loans to/from related parties.
Trade debtors, other debtors and loans to related parties are recognised initially at the transaction price less attributable transaction costs. Trade creditors, other creditors and loans from related parties are recognised initially at transaction price plus attributable transaction costs. Subsequently they are measured at amortised cost using the effective interest method, less any impairment losses in the case of trade and other debtors, and loans to related parties.
Interest bearing borrowings, such bank loans, classified as basic financial instruments are recognised initially at the present value of future payments discounted at a market rate of interest. Thereafter they are stated at amortised cost using the effective interest method.
Cash and cash equivalents comprise cash balances and call deposits. 

 
2.5

Finance costs

Finance costs are charged to profit or loss over the term of the debt using the effective interest method so that the amount charged is at a constant rate on the carrying amount. Issue costs are initially recognised as a reduction in the proceeds of the associated capital instrument.

 
2.6

Interest income

Interest income is recognised in profit or loss using the effective interest method.

 
2.7

Taxation

Tax is recognised in profit or loss except that a charge attributable to an item of income and expense recognised as other comprehensive income or to an item recognised directly in equity is also recognised in other comprehensive income or directly in equity respectively.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the Company operates and generates income.



3.


Employees

The average monthly number of employees, including directors, during the year was 1 (2024 - 1).

Page 3

 
HEALTHCARE INVOICE FINANCE LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 MARCH 2025

4.


Tangible fixed assets





Office equipment
Computer equipment
Total

£
£
£



Cost or valuation


At 31 March 2024
2,492
13,800
16,292


Additions
714
3,596
4,310



At 30 March 2025

3,206
17,396
20,602



Depreciation


At 31 March 2024
1,992
9,147
11,139


Charge for the year on owned assets
329
2,159
2,488



At 30 March 2025

2,321
11,306
13,627



Net book value



At 30 March 2025
885
6,090
6,975



At 30 March 2024
500
4,653
5,153


5.


Debtors

2025
2024
£
£


Trade debtors
112,252
21,682

Other debtors
2,654
3,595

Prepayments and accrued income
214
214

115,120
25,491


Page 4

 
HEALTHCARE INVOICE FINANCE LIMITED
 
 
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 30 MARCH 2025

6.


Creditors: Amounts falling due within one year

2025
2024
£
£

Other taxation and social security
91,774
43,964

Other creditors
158,821
70,754

Accruals and deferred income
2,897
4,793

253,492
119,511



7.


Share capital

2025
2024
£
£
Allotted, called up and fully paid



3 (2024 - 3) Ordinary shares of £1 each
3
3
3 (2024 - 3) B Ordinary shares of £1 each
3
3
3 (2024 - 3) C Ordinary shares of £1 each
3
3

9

9


 
Page 5